Distinguished in FOXG1 Syndrome

Dr. Eric D. Marsh

Pediatric Neurology | Pediatrics | Neurology

Children's Hospital of Philadelphia

Childrens Health Care Associates Inc

3401 Civic Ctr Blvd,

Philadelphia, PA

Distinguished in FOXG1 Syndrome

Children's Hospital of Philadelphia

Childrens Health Care Associates Inc

3401 Civic Ctr Blvd,

Philadelphia, PA

OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eric Marsh is a Pediatric Neurologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Marsh is rated as a Distinguished provider by MediFind in the treatment of FOXG1 Syndrome. His top areas of expertise are Rett Syndrome, Epilepsy, West Syndrome, and CDKL5 Deficiency Disorder.

His clinical research consists of co-authoring 162 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles and participated in 1 clinical trial in the study of FOXG1 Syndrome.

Specialties

Pediatric Neurology

Pediatrics

Neurology

Licenses

Pediatrics in PA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem

Avalon Health Care

MEDICARE PDP

Blue Cross Blue Shield

Capital Blue Cross

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
OTHER MEDICARE PART D
PPO

CareFirst

Cigna

Gateway Health Plan

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE SNP
OTHER MEDICARE PART D

Geisinger

Golden Rule

INSURANCE PLAN
PPO

Health Care Services Corporation

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

Health Partners Plans

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP

Highmark

Horizon Healthcare

Humana

HMO
INDEMNITY
POS
PPO

Independent Health

Medicaid

OTHER MEDICAID
STATE MEDICAID

Medicare

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE PART D

MVP Health

Sentara Healthcare

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE ASSISTANCE PROGRAM
MEDICARE MAPD
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

TeamCare

OTHER COMMERCIAL

UnitedHealthcare

UPMC

Walgreens

MEDICARE DISCOUNT CARD
MEDICARE PDP
OTHER MEDICARE

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 20 Less Insurance Carriers -

Locations

CHILDRENS HEALTH CARE ASSOCIATES INC
3401 Civic Ctr Blvd, Philadelphia, PA 19104

Call: 215-590-1000

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (ENDYMION 2)

Enrollment Status: Terminated

Publish Date: October 08, 2025

Intervention Type: Drug

Study Drug: Soticlestat

Study Phase: Phase 3

A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients

Enrollment Status: Terminated

Publish Date: August 22, 2024

Intervention Type: Drug

Study Drug: JBPOS0101

Study Phase: Phase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS)